GlassScriptPhysician profile
Johnathan Jeffers
NPI 1841829009
$1,155.07
in general payments reported to CMS, 2019-2025
11 companies · $445 in 2025
The $445 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.12 · 2023: $478 · 2024: $211 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $262.30 | 2023 | Lipiview Ocular Surface Interferometer, Meibomian Gland Evaluator, Lipiflow System Activator (Disposable) |
| Abbvie INC. | $208.62 | 2024-2025 | |
| Rxsight INC | $83.43 | 2025 | Rxsight Injector Handpiece, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Biotissue Holdings INC. | $77.70 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $65.25 | 2025 | Xdemvy |
| Alcon Vision LLC | $62.07 | 2025 | Tryptyr, Eysuvis |
| Amgen INC. | $61.72 | 2025 | Tepezza |
| Bausch & Lomb Americas INC. | $34.59 | 2024 | Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $27.30 | 2024 | |
| Oyster Point Pharma, INC. | $19.09 | 2024 | Tyrvaya |
| Harrow Eye, LLC | $15.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnathan Jeffers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.